TES-1025

TES-1025 Suppliers list
Company Name: MedChemexpress LLC  
Tel: 021-58955995
Email: sales@medchemexpress.cn
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Shanghai Rechem science Co., Ltd.  
Tel: 021-31433387 15618786686
Email: sales@rechemscience.com
Company Name: Cool Pharm, Ltd  
Tel: 021-58581007 18019463053
Email: sales@coolpharm.com

TES-1025 manufacturers

  • TES-1025
  • TES-1025 pictures
  • $35.00
  • 2026-07-14
  • CAS:1883602-21-8
  • Purity: 98.81%
  • Supply Ability: 10g
TES-1025 Basic information
Product Name:TES-1025
Synonyms:2-(3-(((5-cyano-6-oxo-4-(thiophen-2-yl)-1,6-dihydropyrimidin-2-yl)thio)methyl)phenyl)acetic acid;TES-1025;Benzeneacetic acid, 3-[[[5-cyano-1,6-dihydro-6-oxo-4-(2-thienyl)-2-pyrimidinyl]thio]methyl]-;inhibit,Inhibitor,TES 1025,TES1025,TES-1025;3-[[[5-cyano-1,6-dihydro-6-oxo-4-(2-thienyl)-2-pyrimidinyl]thio]methyl]phenylacetic acid;TES-1025 (TES1025)
CAS:1883602-21-8
MF:C18H13N3O3S2
MW:383.44
EINECS:
Product Categories:
Mol File:1883602-21-8.mol
TES-1025 Structure
TES-1025 Chemical Properties
Boiling point 602.4±65.0 °C(Predicted)
density 1.45±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 100 mg/mL (260.80 mM)
form Solid
pka4.23±0.10(Predicted)
color White to yellow
Safety Information
MSDS Information
TES-1025 Usage And Synthesis
UsesTES-1025 is a potent and selective human α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD) inhibitor with an IC50 of 13 nM[1].
in vivo

TES-1025 is subjected to in vivo pharmacokinetic studies, following intravenous (IV) and oral (PO) dosings of male CD-1 mice. After the intravenous administration of 0.5 mg/kg, TES-1025 shows low blood clearance, with low volumes of distribution and half-lives (t1/2) of about 5.33 h, although after oral administration at 5 mg/kg, the blood concentration of TES-1025 is quantifiable for up to 8 h. A good systemic exposure is recorded for TES-1025, with a Cmax of 2570 ng/mL reaches at 2 h after dosing. The greater oral exposure of TES-1025 is further confirmed in the liver and kidneys with AUC0-8h of 19 200 h ng/mL and 36 600 h ng/mL, respectively[1].

References[1] Pellicciari R, et al. α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis. J Med Chem. 2018 Feb 8;61(3):745-759. DOI:10.1021/acs.jmedchem.7b01254
TES-1025 Preparation Products And Raw materials
Tag:TES-1025(1883602-21-8) Related Product Information
TES-1025 2-Mercapto-6-oxo-4-(2-thienyl)-1,6-dihydropyrimidine-5-carbonitrile 3,4-diMethoxy-N-(4-(3-nitrophenyl)-5-(piperidin-1-ylMethyl)thiazol-2-yl)benzenesulfonaMide NA 3,4-dimethoxy-N-[4-(3-nitrophenyl)-1,3-thiazol-2-yl]benzenesulfonamide GSK180